| 2 | EndocannabinoidsIBA
06/2015
-
10/2001 |
| 2 | Messenger RNA (mRNA)IBA
01/2002
-
07/2001 |
| 1 | MicroRNAs (MicroRNA)IBA
01/2022 |
| 1 | Biomarkers (Surrogate Marker)IBA
01/2022 |
| 1 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
06/2015 |
| 1 | LipopolysaccharidesIBA
12/2012 |
| 1 | Azithromycin (Zithromax)FDA LinkGeneric
08/2010 |
| 1 | Peptides (Polypeptides)IBA
06/2010 |
| 1 | Calcitriol Receptors (Calcitriol Receptor)IBA
04/2008 |
| 1 | Serotonin (5 Hydroxytryptamine)IBA
03/2008 |
| 1 | Neurotransmitter Agents (Neurotransmitter)IBA
03/2008 |
| 1 | 5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
03/2008 |
| 1 | NF-kappa B (NF-kB)IBA
10/2006 |
| 1 | T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2005 |
| 1 | AntibodiesIBA
05/2003 |
| 1 | Proteins (Proteins, Gene)FDA Link
05/2003 |
| 1 | DNA (Deoxyribonucleic Acid)IBA
01/2002 |
| 1 | EmeticsIBA
10/2001 |
| 1 | CannabinoidsIBA
10/2001 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
10/2001 |
| 1 | methanandamideIBA
10/2001 |
| 1 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2001 |
| 1 | Carbapenems (Carbapenem Antibiotics)IBA
11/2000 |
| 1 | Ceftazidime (Fortum)FDA LinkGeneric
11/2000 |
| 1 | Anti-Bacterial Agents (Antibiotics)IBA
11/2000 |
| 1 | Meropenem (Merrem)FDA LinkGeneric
11/2000 |
| 1 | 1,7- N- heptylene- bis- 9,9'- amino- 1,2,3,4- tetrahydroacridineIBA
03/2000 |